Esther Fernández-Simón

6PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Energy generation, conversion and storage (excl. chemical and electrical)Medical infection agents (incl. prions)Neurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 18, 2026
Correction: Impact of C4BPA on Muscle progenitor cell differentiation: insights for Duchenne muscular dystrophy treatment.

|Apr 17, 2026
Correction: Investigating the role of EGFR signalling in muscle dystrophies: implications for Duchenne muscular dystrophy.

|Mar 19, 2026
Impact of C4BPA on Muscle progenitor cell differentiation: insights for Duchenne muscular dystrophy treatment.

Esther Fernández-Simón, Ainoa Tejedera-Villafranca, Xiomara Fernández-Garabay

|Jan 09, 2026
Investigating the role of EGFR signalling in muscle dystrophies: implications for Duchenne muscular dystrophy.

Esther Fernández-Simón, Ainoa Tejedera-Villafranca, Xiomara Fernández-Garabay

|Oct 27, 2022
Nintedanib Reduces Muscle Fibrosis and Improves Muscle Function of the Alpha-Sarcoglycan-Deficient Mice.

Jorge Alonso-Pérez, Ana Carrasco-Rozas, Maria Borrell-Pages

|Feb 08, 2022
RhoA/ROCK2 signalling is enhanced by PDGF-AA in fibro-adipogenic progenitor cells: implications for Duchenne muscular dystrophy.

Esther Fernández-Simón, Xavier Suárez-Calvet, Ana Carrasco-Rozas

Pageof 1

Frequent Collaborators

4 joint publications

James Clark

4 joint publications

Javier Ramón-Azcón

2 joint publications

Ainoa Tejedera-Villafranca

1 joint publications

Jordi Díaz-Manera